Arcus Biosciences (RCUS) Other Gross PP&E Adjustments (2017 - 2024)
Historic Other Gross PP&E Adjustments for Arcus Biosciences (RCUS) over the last 8 years, with Q4 2024 value amounting to $61.0 million.
- Arcus Biosciences' Other Gross PP&E Adjustments changed 0.0% to $61.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $61.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $61.0 million for FY2024, which is 0.0% changed from last year.
- Latest data reveals that Arcus Biosciences reported Other Gross PP&E Adjustments of $61.0 million as of Q4 2024, which was down 0.0% from $61.0 million recorded in Q4 2023.
- Arcus Biosciences' 5-year Other Gross PP&E Adjustments high stood at $61.0 million for Q4 2023, and its period low was -$104.3 million during Q2 2022.
- For the 5-year period, Arcus Biosciences' Other Gross PP&E Adjustments averaged around -$20.7 million, with its median value being -$6.5 million (2020).
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 834233.41% in 2021, then soared by 16464.72% in 2022.
- Over the past 5 years, Arcus Biosciences' Other Gross PP&E Adjustments (Quarter) stood at $8.5 million in 2020, then plummeted by 865.59% to -$65.0 million in 2021, then soared by 164.65% to $42.0 million in 2022, then soared by 45.24% to $61.0 million in 2023, then changed by 0.0% to $61.0 million in 2024.
- Its Other Gross PP&E Adjustments was $61.0 million in Q4 2024, compared to $61.0 million in Q4 2023 and $42.0 million in Q4 2022.